Building stronger bones, 1 stem cell at a timeJanuary 25, 2008Mesenchymal stem cells (MSCs) are bone marrow-derived cells that are capable of giving rise to various cell types through a process known as differentiation. Although it has been proposed that drugs targeting the in vivo differentiation of these cells might provide a new strategy for regenerative medicine, identifying drugs that are capable of specifically targeting MSCs and that can also regulate their differentiation has proven an enormous obstacle. In a new study, David Scadden and colleagues at Massachusetts General Hospital, Boston, have determined that the antitumor drug bortezomib (Bzb) targets MSCs and leads to bone cell-specific differentiation. Human and mouse MSCs treated with Bzb effectively differentiated into osteoblasts, the cell type responsible for bone formation. Bzb treatment increased bone formation in normal mice and recovered bone loss in mice with an induced form of osteoporosis. The authors therefore concluded that Bzb might be a novel therapy for bone loss in individuals with some types of cancer as well as those with osteoporosis. The clinical importance of these data for the treatment of patients with cancer accompanied by severe bone disease, such as often occurs in individuals with myeloma, is further highlighted in an accompanying commentary by David Roodman at the VA Pittsburgh Healthcare System. Journal of Clinical Investigation | |||||||||||||||||||||
|
Related Stem Cell Current Events and Stem Cell News Articles Mayo researchers explore issues related to multiple myeloma treatment Multiple myeloma (MM) is a cancer of plasma cells that affects approximately 3 in 100,000 people each year. Although there is no cure for this disease, researchers have developed treatments that help relieve pain, control complications, and slow the progress of MM in many patients. Emerging model organisms featured in CSH Protocols Biological research has long relied on a small number of model organisms, species chosen because they are amenable to laboratory research and suitable for the study of a range of biological problems. Reversible 3-D cell culture gel invented Singapore's Institute of Bioengineering and Nanotechnology (IBN), which celebrates its fifth anniversary this year, has invented a unique user-friendly gel that can liquefy on demand, with the potential to revolutionize three-dimensional (3D) cell culture for medical research. What to do with leftover embryos in fertility clinics? The majority of infertility patients are in favor of using left-over embryos for stem cell research and would also support selling left-over embryos to other couples, according to a recent survey. Pittsburgh researchers identify source of multipotent stem cells with broad regenerative potential In a promising finding for the field of regenerative medicine, stem cell researchers at Children's Hospital of Pittsburgh of UPMC have identified a source of adult stem cells found on the walls of blood vessels with the unlimited potential to differentiate into human tissues such as bone, cartilage and muscle. Stem cells may solve mystery of early pregnancy breast cancer protection The answer to why an early pregnancy seems to protect against breast cancer could rest with a decrease in stem cells found after animals have given birth, said researchers at Baylor College of Medicine in a report that appears in the current issue of the journal Stem Cell. Scientists identify genes capable of regulating stem cell function Scientists from The Forsyth Institute, Boston, MA, and the Howard Hughes Medical Institute at the University of Utah School of Medicine have developed a new system in which to study known mammalian adult stem cell disorders. Embryonic stem cells might help reduce transplantation rejection Researchers have shown that immune-defense cells influenced by embryonic stem cell-derived cells can help prevent the rejection of hearts transplanted into mice, all without the use of immunosuppressive drugs. Stem cell regeneration repairs congenital heart defect Mayo Clinic investigators have demonstrated that stem cells can be used to regenerate heart tissue to treat dilated cardiomyopathy, a congenital defect. OU Cancer Institute Scientists Identify New Cancer Stem Cell Marker; Developing Drug to Stop Cancer Recurrence After years of working toward this goal, scientists at the OU Cancer Institute have found a way to isolate cancer stem cells in tumors so they can target the cells and kill them, keeping cancer from returning. More Stem Cell Current Events and Stem Cell News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||